Evidence map›Paper›PMID 41971038›Full record

ArticleEuropean heart journal. Imaging methods and practice2026

New CT-based dural ectasia criteria using machine learning to diagnose Marfan and Loeys-Dietz syndromes.

Claire Bouleti, Raphael Thuillier, Yoann Moeuf, Gaspard Suc, Laurent Gouya, Florence Arnoult, Noemie Tence, Florence Nicot, Benjamin Alos, Margaux Gouysse and 6 more

Abstract read
In one paragraph

Article in European heart journal. Imaging methods and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Claire BouletiClinical Investigation Center (INSERM 1402), FACT and Poitiers Hospital, Cardiology Department, University of Poitiers, CHU de Poitiers, 2 Rue de la Milétrie, Poitiers 86000, France.ORCID https://orcid.org/0000-0001-6922-0093
Raphael ThuillierInserm Unit Ischémie Reperfusion, Métabolisme et Inflammation Stérile en Transplantation (IRMETIST), UMR U1313, Poitiers F-86073, France.
Yoann MoeufCardiology Department, Saint-Joseph Hospital, Paris 75014, France.
Gaspard SucCardiology Department, Bichat University Hospital, AP-HP, Paris 75018, France.ORCID https://orcid.org/0000-0003-2273-1528
Laurent GouyaReference Center for Marfan Disease, Genetic Department, Université Paris Cité, Bichat University Hospital, AP-HP, Paris 75018, France.
Florence ArnoultReference Center for Marfan Disease, Cardiology Department, U1148 LVTS, INSERM, Université Paris Cité, Bichat University Hospital, AP-HP, Paris 75018, France.
Noemie TenceCardiology Department, Private Hospital Jacques Cartier, Massy 91300, France.
Florence NicotCardiology Department, Hospital of Versailles, Le Chesnay 78150, France.
Benjamin AlosClinical Investigation Center (INSERM 1402), FACT and Poitiers Hospital, Cardiology Department, University of Poitiers, CHU de Poitiers, 2 Rue de la Milétrie, Poitiers 86000, France.
Margaux GouysseBiostatistics Department, Ecole Nationale de la Statistique et de L'Administration Economique ENSAE ParisTech, Palaiseau 91120, France.
Olivier MilleronReference Center for Marfan Disease, Cardiology Department, U1148 LVTS, INSERM, Université Paris Cité, Bichat University Hospital, AP-HP, Paris 75018, France.ORCID https://orcid.org/0000-0002-6517-0559
Phalla OuRadiology Department, Bichat University Hospital, AP-HP, Paris 75018, France.ORCID https://orcid.org/0000-0002-2034-5001
Nicolas GlattR&D Department, CEO Clinityx Company, Boulogne-Billancourt 92100, France.
Maria TchitchinadzeReference Center for Marfan Disease, Cardiology Department, U1148 LVTS, INSERM, Université Paris Cité, Bichat University Hospital, AP-HP, Paris 75018, France.
Philippe Gabriel StegINSERM U1148, FACT and AP-HP, Hôpital Bichat, Université Paris-Cité, Paris 75018, France.
Guillaume JondeauReference Center for Marfan Disease, Cardiology Department, U1148 LVTS, INSERM, Université Paris Cité, Bichat University Hospital, AP-HP, Paris 75018, France.ORCID https://orcid.org/0000-0002-0101-2076

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: Dural ectasia (DE) is a criterion for Marfan syndrome (MFS) diagnosis. However, there is no agreement on its diagnosis. We identified new DE criteria on CT-scan imaging using machine-learning (ML) and aimed to evaluate their performance for MFS and Loeys-Dietz detection. Methods and results: MFS patients with FBN1 pathogenic variant, who underwent a complete CT-scan were included and matched 1:1 with controls. The conventional criteria for DE were assessed, as well as new criteria identified by ML (generalized linear model and random forest), regarding MFS diagnostic performance. The new DE criteria were then evaluated for identification of Loeys-Dietz patients with TGFßR1/2 and SMAD3 pathogenic variants. A user-friendly online interface was finally developed to predict the probability of MFS or Loeys-Dietz diagnosis.Between November 2010 and January 2017, 93 MFS patients and their matched controls were included. Mean age was 39 ± 13 years with 45% of women. Conventional definitions of DE showed poor diagnostic performance for MFS: AUC 0.68 (0.61-0.74).The new DE criteria, based on simple CT-scan measurements (antero-posterior diameter of the spinal canal and scalloping) on vertebrae L1, L2 and S1, achieved AUC 0.84 (0.69-0.94). These criteria outperformed the Ghent-criteria for MFS diagnosis. Moreover, in 46 patients with TGFßR1/2 and 40 with SMAD3 pathogenic variants, the new criteria also achieved good diagnostic performance (AUC 0.83 (0.73-0.90) and 0.80 (0.70-0.88) respectively). Conclusion: New CT-scan DE criteria showed good performance for detecting MFS or Loeys-Dietz syndromes. Given the importance of early diagnosis, these new simple criteria offer a promising screening tool.

Indexed as

diagnostic performancedural ectasiaLoeys-Dietz syndromeMarfan syndrome

Identifiers

PMID41971038
PMCPMC13064652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.